Skip to content
Contact Us
iStock-1455004192 (1) iStock-1455004192 (1)

Data Monitoring Committee Services

Reliable and independent oversight at the speed of Precision.
At Precision for Medicine, we uphold the highest standards of patient safety and trial integrity through our independent data monitoring committee (DMC) services. Combining deep expertise, a solid infrastructure, and efficient processes, we deliver critical safety and statistical reports swiftly and accurately, ensuring your trial’s success is monitored with the utmost precision and care.

Safeguarding your study with expert DMC services

Precision’s DMC services, covering a vast array of therapeutic areas and complex trial designs, focus on safeguarding patient outcomes and ensuring bias-free, informed decision-making processes.
  • Committee Setup
  • Customizing Analysis
  • Global Expertise

  • Establishing an Unbiased Safety Oversight Framework

    By rigorously selecting DMC members for their medical, scientific, and statistical expertise, Precision guarantees an unbiased and conflict-free evaluation process. This foundational step ensures that every safety oversight decision is made with the utmost integrity, directly contributing to the trial's credibility and success.

    iStock-998338578

  • Customized Safety Analysis for Informed Decisions

    Precision’s tailored analysis and reporting adapt to the unique needs of each clinical study, ensuring novel therapies are evaluated with precision. Our statistical experts deliver impactful analysis, enabling accurate monitoring of patient safety and enhancing decision-making for trial progression 
    Custom analysis

  • Optimizing DMC Strategies with Global Insights

    Our global presence in over 50 countries enables Precision to develop DMC strategies that are not only cohesive but also optimized for local regulatory landscapes and patient populations. This global network ensures that your trials benefit from nuanced strategies that prioritize patient outcomes, regardless of location
    Hybrid outsourcing- Global teams
DMC dashboards

Tailored DMC oversight for clinical precision

As clinical trials continue to increase in complexity, Precision's data monitoring committee (DMC) services stand out by offering a blend of scalability and customization, crafted to navigate the intricacies of each unique study with unmatched precision. Our commitment to excellence extends through every facet of trial oversight—from the meticulous selection of committee members to the development of study-specific charters and robust administration. By providing comprehensive programming, validation, and secure reporting, alongside detailed coordination and documentation practices, we ensure seamless compliance and safeguard trial integrity. Precision’s approach not only underscores our dedication to precision but also amplifies the effectiveness and safety of clinical programs. Our DMC services can include:

  • Committee member selection
  • Charter development tailored to your study requirements
  • Administration and management
  • Programming and validation of DMC deliverables 
  • Secure reporting to DMC members 
  • Meeting coordination, attendance and minutes generated
  • Secure documentation archiving for TMF compliance
  • Roles as blinded and unblinded statisticians
    DMC reporting facilitation with Clarity

Precision technologies drive efficiency & insight

Unleash the power of MetaVate and Clarity, our cutting-edge technologies, to revolutionize DMC reporting and unlock actionable insights, elevating the efficiency of data management and analysis
  • MetaVate
  • Clarity

  • Accelerate Data Transformation with MetaVate

    With MetaVate, we automate the conversion of clinical data from any source to any target, including SDTM, ADaM and third-party data. For more frequent data cuts and interim reporting, MetaVate can help you accelerate outcomes by complimenting statistical programming efforts.

    800x400_AdobeStock_354007466

  • Enhance DMC Reporting with Clarity

    Our clinical data intelligence platform, Clarity has an inbuilt DMC module that closely monitors and visually reports on parameters required for DMC meetings. With a carefully built access-controlled environment, Clarity facilitates near-real-time reporting while ensuring unbiased reviews.
    Data visualization

Stay informed with Precision insights

Keep up with the latest developments on data monitoring committees and advances in biostatistics through our blog.

Explore our blog
Read: Pros and Cons: Innovative Study Designs vs. Traditional FIH Study Designs vs. Traditional FIH

Clinical Trials

Pros and Cons: Innovative Study Designs vs. Traditional FIH

|
    has not third author: true, (SizeLimitingPyMap: {main={hs_id=159488778854, hs_child_table_id=0, hs_updated_at=1715695005945, hs_published_at=1737992486362, description=Rosa Canals López has 15 years of experience in managing Phase I-IV clinical trials, including >7 years of Clinical Management experience. Her focus is on Phase I studies and CAR-T, with additional experience in oncology, hematology, pediatrics, infectious diseases, cardiology, and nephrology., avatar=Image{width=533,height=710,url='https://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/PfM%20Website/Headshots/Headshots%20no%20background/Rosa-Canals.png',altText='Rosa-Canals',fileId=167374630834}, linkedin=https://www.linkedin.com/in/rosa-maria-canals-l%C3%B3pez-74902194, hs_name=, hs_path=, lastname=Canals López, hs_initial_published_at=1716136551646, hs_created_at=1709645745085, hs_is_edited=false, hs_deleted_at=0, name=Rosa, job=, slug=rosa-canals-lópez, email=, hs_updated_by_user_id=26433386}, second={}, third={}})
  • Rosa Canals López avatar

    Rosa Canals López
Discover
Read: Phase 1/2 Combination Studies: Best Practices When Moving from Escalation to Expansion Combination Studies

Clinical Trials - Early Phase Research - Oncology

Phase 1/2 Combination Studies: Best Practices When Moving from Escalation to Expansion

|
    has not third author: true, (SizeLimitingPyMap: {main={hs_id=159488778894, hs_child_table_id=0, hs_updated_at=1714461151531, hs_published_at=1737992486362, description=Vincent Shortino is a Principal Clinical Trial Manager, bringing more than 20 years of experience to Precision. His experience spans all major therapeutic areas with a heavy emphasis on Cardiovascular and Rare Indications, across Phases I–IV. He brings solid perspectives inclusive of sites, pharma and CROs from his previous roles of Study Coordinator, Site Director, CRA, and Clinical Trial Manager., avatar=Image{width=576,height=576,url='https://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/PfM%20Website/Headshots/Headshots%20no%20background/Vincent%20Shortino.webp',altText='Vincent Shortino',fileId=165892429964}, linkedin=https://www.linkedin.com/in/vincent-shortino-954b3857, team=[{id=163080551773, name='Clinical Solutions Leadership'}], hs_name=, hs_path=, lastname=Shortino, hs_initial_published_at=1716212769184, hs_created_at=1709645745125, hs_is_edited=false, hs_deleted_at=0, name=Vincent, job=Principal Clinical Trial Manager, slug=vincent-shortino, email=, hs_updated_by_user_id=26433386}, second={}, third={}})
  • Vincent Shortino avatar

    Vincent Shortino
Discover
Read: Phase III Case Study: Adapting in the Face of Adversity Phase III Case Study

Clinical Trials

Phase III Case Study: Adapting in the Face of Adversity

|
    has not third author: true, (SizeLimitingPyMap: {main={hs_id=159488778845, hs_child_table_id=0, hs_updated_at=1709645745076, hs_published_at=1737992486362, description=Brian Beus is a Principal Biostatistician with more than 25 years experience supporting the statistical analysis of data through all phases of clinical trials across many therapeutic areas. He has extensive experience in leading teams and working with sponsors through study design, protocol development, adaptive design, statistical analysis plans, statistical analysis, clinical study reports, regulatory submissions, and regulatory responses., avatar=Image{width=150,height=150,url='https://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/PfM%20Website/PfMxMarkentive/authors/brian-beus.webp',altText='',fileId=null}, linkedin=https://www.linkedin.com/in/brian-beus-66033333, hs_name=, hs_path=, lastname=Beus, hs_initial_published_at=1716212769184, hs_created_at=1709645745076, hs_is_edited=false, hs_deleted_at=0, name=Brian, job=, slug=brian-beus, email=, hs_updated_by_user_id=26433386}, second={}, third={}})
  • Brian Beus avatar

    Brian Beus
Discover

Specialized capabilities in every stage of clinical development

Leverage an integrated infrastructure that reduces the inefficiencies inherent in complex development. Integrate lab and trial execution to increase speed to market. Incorporate manufacturing expertise for advances therapies to ensure scalability. Precision can customize and converge our capabilities for your program's unique needs.

  • Discover Explore
    clinical-trial-support

    Global CRO
    Services

    Award-winning CRO with deep oncology and rare disease expertise

    Explore
  • Discover Explore
    specialty-lab-services

    Global Laboratory
    Services

    Exceptional translational and biomarker sciences with global central lab services

    Explore
  • Discover Explore
    Manufacturing

    Manufacturing
    Solutions

    Pioneers in planning, building and maintaining manufacturing at scale for pharma and biotechs.

    Explore